Hepatocellular Carcinoma Biomarkers, an Imminent Need
Overview
Overview
Journal
World J Gastrointest Oncol
Publisher
Baishideng Publishing Group
Date
2021 Dec 2
PMID
34853655
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Hepatocellular carcinoma (HCC) is the most common malignant neoplasm of the liver and one of the deadliest cancers worldwide. The identification of novel, highly specific and more sensitive biomarkers for HCC is crucial because existing ones are deficient and non-confirmatory without histological biopsy or imaging techniques.
Citing Articles
Udupi A, Shetty S, Aranjani J, Kumar R, Bharati S Drug Deliv Transl Res. 2024; 15(3):1023-1042.
PMID: 38990437 PMC: 11782354. DOI: 10.1007/s13346-024-01655-1.
References
1.
Rattan P, Minacapelli C, Rustgi V
. The Microbiome and Hepatocellular Carcinoma. Liver Transpl. 2020; 26(10):1316-1327.
DOI: 10.1002/lt.25828.
View
2.
Singh G, Yoshida E, Rathi S, Marquez V, Kim P, Erb S
. Biomarkers for hepatocellular cancer. World J Hepatol. 2020; 12(9):558-573.
PMC: 7522562.
DOI: 10.4254/wjh.v12.i9.558.
View
3.
Chen W, Mao Y, Liu C, Wu H, Chen S
. Exosome in Hepatocellular Carcinoma: an update. J Cancer. 2021; 12(9):2526-2536.
PMC: 8040701.
DOI: 10.7150/jca.54566.
View
4.
Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H
. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2018; 68(6):1014-1023.
PMC: 6580753.
DOI: 10.1136/gutjnl-2017-315084.
View
5.
Duan J, Wu Y, Liu J, Zhang J, Fu Z, Feng T
. Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine. J Hepatocell Carcinoma. 2019; 6:151-166.
PMC: 6805787.
DOI: 10.2147/JHC.S224849.
View